CGC
Canopy GrowthCGC
CGC
About: Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
Employees: 960
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
181% more call options, than puts
Call options by funds: $5.19M | Put options by funds: $1.85M
30% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 33
1.72% more ownership
Funds ownership: 7.13% [Q4 2024] → 8.85% (+1.72%) [Q1 2025]
10% less funds holding
Funds holding: 223 [Q4 2024] → 201 (-22) [Q1 2025]
34% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 41
46% less capital invested
Capital invested by funds: $23.9M [Q4 2024] → $12.8M (-$11.1M) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for CGC.
Financial journalist opinion
Based on 18 articles about CGC published over the past 30 days
Neutral
MarijuanaStocks
9 hours ago
Cannabis Stocks Are at a Turning Point: Is Now the Time to Invest?
Currently, the cannabis industry is in another transitional period, presenting both challenges and potential opportunities for investors. After several years of volatility and downward trading, marijuana stocks are gaining renewed attention. Particularly as regulatory momentum builds and valuations reach attractive lows. While the sector has seen a sharp plunge over the past few years, mainly driven by market saturation, lagging federal reform in the U.S., and capital outflows.
Positive
Zacks Investment Research
9 hours ago
Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now?
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Neutral
Business Wire
1 day ago
Canopy Growth to Strengthen Balance Sheet with Early Prepayments Set to Reduce Term Loan by US$50 Million; Annual Cash Interest Expense Expected to be Reduced by US$6.5 Million
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it has entered into an agreement (the “Agreement”) with certain of its lenders (the “Lenders”) to make three prepayments that are expected to reduce the Company's Senior Secured Term Loan (the “Term Loan”) by US$50 Million by March 31, 2026. The Agreeme.
Positive
Zacks Investment Research
5 days ago
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.14, marking a +2.7% move from the previous day.
Neutral
Business Wire
5 days ago
Canopy Growth to Report First Quarter Fiscal 2026 Financial Results on August 8, 2025
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the first quarter fiscal year 2026 ended June 30, 2025 before financial markets open on August 8, 2025. Following the release of its first quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, Interim CFO on August 8, 2025 at 10 AM Eastern Time (ET). Webcast Informa.
Negative
Zacks Investment Research
6 days ago
Canopy Growth Corporation (CGC) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.11, marking a -5.13% move from the previous day.
Positive
MarijuanaStocks
1 week ago
Top Canadian Cannabis Picks for U.S. Market Expansion in 2025
As cannabis markets shift this week, Canadian cannabis stocks are once again gaining investor attention. At the same time, the U.S. industry continues to grow rapidly. In 2024, legal cannabis sales in the U.S. reached nearly $39 billion. Projections suggest that the number could climb past $44 billion in 2025. Growth is expected to continue at a strong pace through the decade. Despite this momentum, federal legalization remains stalled. However, several U.S. states are pushing forward with their own reform efforts. This steady progress at the state level continues to attract interest. Canadian companies with U.S. exposure stand to benefit from this evolving landscape. As a result, watching top-performing Canadian cannabis stocks this week could reveal key breakout opportunities.
Neutral
Zacks Investment Research
1 week ago
Canopy Growth Corporation (CGC) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.09, marking a -1.8% move from the previous day.
Positive
Zacks Investment Research
2 weeks ago
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Positive
MarijuanaStocks
2 weeks ago
3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce
2025 has been a troubled time for marijuana stock investors. With a lack of momentum and no sign of any upward trading, what are shareholders to do? Now, the cannabis industry outside of the public sector has been doing phenomenally. Some cannabis companies continue to grow and become even bigger and profitable. At this time, the legal market still faces an uphill climb, but as long as companies can fulfill the increase in consumer demand there is a light at the end of the tunnel.
Charts implemented using Lightweight Charts™